Private equity group Advent has shortlisted four prospective buyers in the sale of its Dutch medical supplier Mediq, which could fetch more than 1 billion euros (890.8 million pounds), sources close to the matter said.
Buyout groups Bain, CD&R, CapVest and Triton have proceeded to the second round of bidding, they said, adding that final offers were due in early December.
Advent and the prospective buyers declined to comment or were not immediately available for comment.Advent and the prospective buyers declined to comment or were not immediately available for comment.
Mediq is being marketed on the basis of full-year earnings before interest, tax, depreciation and amortization (EBITDA) of up to 106 million euros ($125 million), though some potential bidders are working on assumptions of core earnings closer to 70 million euros, the sources said.
Mediq, which supplies pharmaceuticals and medical gear to clinics and patients, is expected to be valued at 12-13 times its estimated core earnings, they said.Mediq, which supplies pharmaceuticals and medical gear to clinics and patients, is expected to be valued at 12-13 times its estimated core earnings, they said.
Advent took Mediq private in 2013 for 819 million euros and has since strengthened the company through a string of acquisitions, such as that of Britain’s H&R Healthcare and Norway’s Puls AS.
Source: Reuters
Can’t stop reading? Read more
US Pipeline Operator ONEOK Inks Two Deals for $5.9 Billion
US pipeline operator ONEOK Inc. agreed to buy a Permian Basin rival and a controlling stake in...
Blackstone Is Said to Seek A$5.5 Billion Loan for AirTrunk Bid
Private equity firm Blackstone Inc. is in discussions with banks for a five-year loan of about...
Thrive Capital to lead multi-billion dollar OpenAI investment round at $100bn valuation
OpenAI, the company behind the popular AI tool ChatGPT, is in advanced talks to secure several...